Limagne Emeric

Has grant

Junior Professor Chair

Université de Bourgogne

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Limagne Emeric is a Junior Professor Chair at Université de Bourgogne, France. His research encompasses the immune response in cancer therapy, with recent articles focusing on topics such as the characterization of pseudoprogression in metastatic non-small cell lung cancer, novel cancer vaccines for colorectal cancer, and the effects of radiochemotherapy on immune responses in glioblastoma. He is actively involved in exploring innovative treatments that combine immunotherapy and radiotherapy to enhance patient outcomes.

Recent Grants

Grant: Close

Induction of CXCR3-associated chemokines and sensitization of "cold" tumors to immunotherapy by screening of novel chemotherapy/targeted therapy combinations – ChemoKin

Open Date: 2022-10-23

Close Date: 2026-10-22

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (8)

Céline GONGORA

INSERM U1148

FRANCE

View details

Lionel Apetoh

UNITED STATES

View details

Celine Trinh Le Vi Kieu

National Cancer Institute

UNITED STATES

View details

Adélie DUMONT

Université de Bourgogne

FRANCE

View details

charles THOMAS

Associate Professor

Université de Bourgogne

FRANCE

View details

David MASSON

Full professor

Université de Bourgogne

FRANCE

View details

Tony Jourdan

Université Bourgogne Europe

FRANCE

View details

Mickael Rialland

Université de Bourgogne

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Limagne Emeric

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, <i>KEAP1/STK11</i> co-mutated metastatic NSCLC.

Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer.

Effect of radiochemotherapy on peripheral immune response in glioblastoma.

Targeting two radiation-induced immunosuppressive pathways to improve the efficacy of normofractionated radiation therapy in a preclinical colorectal cancer model.

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.

Protocol for simultaneous analysis of peripheral and intratumoral lymphocyte function by flow cytometry.

First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial.

Combining radiotherapy and NK cell-based therapies: The time has come.

Simultaneous isolation of CD45 tumor-infiltrating lymphocytes, tumor cells, and associated fibroblasts from murine breast tumor model by MACS.

Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-β receptors

Collaborators (8)

Céline GONGORA

Lionel Apetoh

Celine Trinh Le Vi Kieu

Adélie DUMONT

charles THOMAS

David MASSON

Tony Jourdan

Mickael Rialland

Make your next move.